Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing

International Wound Journal

Volumn 8, Issue 4, 2011, Pages 375-384

  Edmondson, Margaret ^a   Newall, Nelly ^a,b   Carville, Keryln ^a,b   Smith, Joanna ^a   Riley, Thomas V ^c   Carson, Christine F ^d  

^a Silver Chain   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Acute wound; Chronic wound; Melaleuca alternifolia; MRSA decolonisation; Tea tree oil; Wound healing

Indexed keywords

NOVABAC; TEA TREE OIL; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; CHRONIC WOUND; CLINICAL ARTICLE; CORYNEBACTERIUM; DECUBITUS; ESCHERICHIA COLI; FEMALE; FOOT ULCER; GRAM POSITIVE BACTERIUM; HERPES ZOSTER; HUMAN; LEG ULCER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; SWAB TEST; TREATMENT OUTCOME; WOUND ASSESSMENT; WOUND CARE; WOUND DEHISCENCE; WOUND DRESSING; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; MALE; MELALEUCA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OILS; PHYTOTHERAPY; PILOT PROJECTS; PLANT PREPARATIONS; SKIN; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

EID: 79960211892     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00801.x     Document Type: Article

References (27)

1. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other properties. Clin Microbiol Rev 2006;19:50-62.
2. Carson CF, Cookson BD, Farrelly HD, Riley TV. Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 1995;35:421-24.
3. Carson CF, Hammer KA, Riley TV. In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. J Antimicrob Chemother 1996;37:1177-8.
4. Hammer KA, Carson CF, Riley TV. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 1996;24:186-9.
5. Nelson RRS. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1997;40:305-6.
6. Elsom GKF, Hide D. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimicrob Chemother 1999;43:427-8.
7. Chan CH, Loudon KW. Activity of tea tree oil on methicillin-resistant Staphylococcus aureus (MRSA) [letter]. J Hosp Infect 1998;39:244-5.
8. Brady A, Loughlin R, Gilpin D, Kearney P, Tunney M. In vitro activity of tea-tree oil against clinical skin isolates of methicillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 2006;55:1375-80.
9. La Plante KL. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2007;57:413-8.
10. Mayaud L, Carricajo A, Zhiri A, Aubert G. Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol 2008;47:167-73.
11. Hayes AJ, Markovic B. Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity. Food Chem Toxicol 2002;40:535-43.
12. Loughlin R, Gilmore BF, McCarron PA, Tunney MM. Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells. Lett Appl Microbiol 2008;46:428-33.
13. Davis A, O'Leary J, Muthaiyan A, Langevin M, Delgado A, Abalos A, Fajardo A, Marek J, Wilkinson B, Gustafson J. Characterization of Staphylococcus aureus mutants expressing reduced susceptibility to common house-cleaners. J Appl Microbiol 2005;98:364-72.
14. Banes-Marshall L, Cawley P, Phillips CA. In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci 2001;58:139-45.
15. Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonisation. J Hosp Infect 2004;56:283-6.
16. Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chron Dis 1961;13:346-53.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests: approved standard, 10th edn. M02-A10. Wayne, Philadelphia, USA: Clinical and Laboratory Standards Institute, 2009.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement M100-S20. Wayne, Philadelphia, USA: Clinical and Laboratory Standards Institute, 2010.
19. Santamaria N, Carville K, Ellis I, Prentice J. The effectiveness of digital imaging and remote expert wound consultation on healing rates in chronic lower leg ulcers in the Kimberley region of Western Australia. Prim Intention 2004;12:62-4, 66-8, 70.
20. International Organisation for Standardisation. ISO 4730: oil of Melaleuca, terpinen-4-ol type (tea tree oil). Geneva: International Organisation for Standardisation, 2004.
21. Caelli M, Porteous J, Carson CF, Heller R, Riley TV. Tea tree oil as an alternative topical decolonisation agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:236-7.
22. Bowler WA, Bresnahan J, Bradfish A, Fernandez C. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting. Infect Cont Hosp Epidemiol 2010;31:269-75.
23. Chaudhuri A, Cogswell L, Quick CRG. A pilot evaluation of tea tree oil in the management of chronic venous leg ulcers. Phlebology 2005;20:134-7.
24. Gravett P. Aromatherapy treatment for patients with Hickman line infection following high-dose chemotherapy. Int J Aromather 2001;11:18-9.
25. Söderberg TA, Johansson A, Gref R. Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 1996;107:99-109.
26. Hayes AJ, Leach DN, Markham JL. In vitro cytotoxicity of Australian tea tree oil using human cell lines. J Essent Oil Res 1997;9:575-82.
27. Faoagali J, George N, Leditschke JF. Does tea tree oil have a place in the topical treatment of burns? Burns 1997;23:349-51.